FOR IMMEDIATE RELEASE
The Wall Street Minute with Rhonda Swan features David Rojas, founder and CEO of Blue Castle Ventures and Evocraft Labs™on the main financial information platforms
Featured Image:
https://drive.google.com/file/d/1Nz_GkCKibDCt_2ZIJw_33BFw6dQ5Kqyo/view?usp=drive_link
New York, NY, January 7, 2026 — The Wall Street Minute with David Rojas will premiere on January 12, 2026 on major financial media platforms including Bloomberg, CNBC, Fox Business and Newsmax.
Hosted by a media strategist and entrepreneur Rhonda Swanthe segment features an exclusive interview with David Rojasfounder and CEO of Blue Castle Companies and Evocraft laboratories™. The episode offers a candid, hands-on conversation about the future of finance, personalized innovation, and the growing intersection of wealth, health, and human performance.
2nd image inside the article:
https://drive.google.com/file/d/1mYjmigDltO-A47ZrfqOAfneLQVTMskgd/view?usp=drive_link
David Rojas is a Colombian entrepreneur and investor best known for founding Blue Castle Ventures, a multinational holding company operating in the United States, Canada, Chile and Colombia. Through Blue Castle, Rojas has built a diverse ecosystem spanning alternative finance, biotechnology, real estate and human enhancement technologies, all guided by a long-term value creation strategy.
Under his leadership, Blue Castle Ventures launched pioneering initiatives such as Evocraft Labs™, a biotechnology division focused on longevity, regenerative medicine and performance optimization. Known for his strategic foresight and disciplined execution, Rojas represents a new generation of leaders who are redefining the relationship between science, finance and human progress. Its work reflects a clear mission: to build sustainable systems that develop human potential and reshape the future of health and prosperity.
During the interview, Rojas describes Blue Castle Ventures as an incubator for forward-thinking projects designed to anticipate market changes before they happen. It identifies biotechnology as one of the most significant growth sectors over the next five years, placing Blue Castle at the forefront of this rapidly evolving space.
A focal point of the discussion is the company’s expansion into personalized health solutions through Evo Labs, where Blue Castle develops treatments tailored to the individual. Rojas explains that the same philosophy behind personalized financial strategies now guides their approach to health, recognizing that no two people respond the same way to treatment or investing.
Swan highlights Blue Castle’s broader mission to restore leadership and empower individuals through generational wealth creation across multiple platforms. Together, Swan and Rojas explore how education, personalization, and long-term thinking are reshaping financial and health landscapes.
The Wall Street Minute with David Rojas delivers concise, high-impact insights from influential leaders shaping the global economy, making complex ideas accessible to audiences around the world.
Broadcast date: January 12, 2026
Platforms: Bloomberg, CNBC, Fox Business, Newsmax
For more information and upcoming appearances, stay tuned THE Wall Street Minutes.
3rd image inside the article:
https://drive.google.com/file/d/1gwhBi1wPg3yJJEtrmsUl1TNNLMeC_5ee/view?usp=drive_link
About Unstoppable Brand Agency
Unstoppable branding agency (UBA) is a global leader in media and brandingwith offices in Beverly Hills, New York, Panama City Beach and Bali. Founded and led by a visionary CEO Rhonda SwanUBA empowers thought leaders, entrepreneurs and executives to amplify their influence on a global scale. The agency specializes in achieving high-level visibility with leading media and influential financial networks, positioning clients as trusted authorities in their industries. Through strategic storytelling, targeted media placements and innovative digital campaigns, UBA helps brands expand their reach, build credibility and leave a lasting impact on their audiences.
Media Contact:
Unstoppable branding agency
310 729‑5578
(email protected)
